Skip to Content

Acetohydroxamic acid Pregnancy and Breastfeeding Warnings

Acetohydroxamic acid is also known as: Lithostat

Medically reviewed on September 11, 2017

Acetohydroxamic acid Pregnancy Warnings

Acetohydroxamic acid has been assigned to pregnancy category X by the FDA. Animal studies have revealed teratogenicity (retarded and/or clubbed rear leg, exencephaly, and encephalocele). There are no controlled data in human pregnancy. Acetohydroxamic acid is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be informed of the potential hazard to the fetus.

See references

Acetohydroxamic acid Breastfeeding Warnings

There are no data on the excretion of acetohydroxamic acid into human milk. Because many drugs are excreted into human milk, and because of the potential for serious adverse reactions in nursing infants from acetohydroxamic acid, a decision should be made to discontinue nursing or the drug, taking into account the significance of the drug to the mother's well being.

See references

References for pregnancy information

  1. "Product Information. Lithostat (acetohydroxamic acid)." Mission Pharmaceutical Company, San Antonio, TX.

References for breastfeeding information

  1. "Product Information. Lithostat (acetohydroxamic acid)." Mission Pharmaceutical Company, San Antonio, TX.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide